Kancera AB (publ)
SSE:KAN.ST
4.095 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.035 | 0.753 | 1.704 | 0.09 | 3.216 | 0.358 | 0.113 | 0.308 | 0.282 | 0.47 | 1.813 | 3.839 | 7.069 | 0 |
| Cost of Revenue
| 3 | 0.36 | 0.32 | 0.027 | 0.096 | 0.072 | 0.074 | 0.063 | 0.074 | 0.306 | 0.53 | 2.867 | 5.611 | 0 |
| Gross Profit
| -1.965 | 0.393 | 1.384 | 0.063 | 3.12 | 0.286 | 0.039 | 0.245 | 0.208 | 0.164 | 1.283 | 0.972 | 1.458 | 0 |
| Gross Profit Ratio
| -1.899 | 0.522 | 0.812 | 0.7 | 0.97 | 0.799 | 0.345 | 0.795 | 0.738 | 0.349 | 0.708 | 0.253 | 0.206 | 0 |
| Reseach & Development Expenses
| 57.989 | 45.608 | 42.634 | 39.279 | 34.507 | 45.24 | 51.069 | 19.089 | 20.355 | 13.692 | 7.533 | 28.882 | 23.038 | 4.763 |
| General & Administrative Expenses
| 6.347 | 4.685 | 3.62 | 11.66 | 5.404 | 4.307 | 3.93 | 2.907 | 3.943 | 1.911 | 3.375 | 3.473 | 2.371 | 2.405 |
| Selling & Marketing Expenses
| 1.741 | 2.394 | 0.706 | 0.934 | 1.202 | 1.132 | 1.446 | 0.531 | 0.805 | 0.656 | 0.779 | 1.91 | 1.403 | 0 |
| SG&A
| 8.088 | 7.079 | 4.326 | 12.594 | 6.606 | 5.439 | 5.376 | 3.438 | 4.748 | 2.567 | 4.154 | 5.383 | 3.774 | 2.405 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 63.077 | 52.687 | 46.96 | 49.231 | 39.031 | 46.743 | 56.318 | 22.527 | 19.894 | 16.259 | 11.687 | 34.265 | 26.812 | 7.168 |
| Operating Income
| -65.042 | -51.934 | -45.256 | -46.515 | -35.655 | -45.921 | -56.143 | -22.282 | -19.686 | -16.095 | -10.404 | -33.293 | -18.372 | -7.168 |
| Operating Income Ratio
| -62.843 | -68.969 | -26.559 | -516.833 | -11.087 | -128.271 | -496.841 | -72.344 | -69.809 | -34.245 | -5.739 | -8.672 | -2.599 | 0 |
| Total Other Income Expenses Net
| 0.153 | -0.55 | -0.43 | -8.101 | -0.442 | -0.014 | -0.055 | -0.026 | 0.074 | 0.116 | 2.986 | -0.195 | -0.038 | 0.021 |
| Income Before Tax
| -64.889 | -52.484 | -45.686 | -47.558 | -36.095 | -45.935 | -56.198 | -22.308 | -19.612 | -15.979 | -7.418 | -33.488 | -18.41 | -7.147 |
| Income Before Tax Ratio
| -62.695 | -69.7 | -26.811 | -528.422 | -11.224 | -128.31 | -497.327 | -72.429 | -69.546 | -33.998 | -4.092 | -8.723 | -2.604 | 0 |
| Income Tax Expense
| 0 | -0.432 | -0.413 | -2.544 | -0.226 | -0.251 | -0.19 | -0.006 | 0.075 | 0.116 | 3.001 | -0.075 | -3.842 | 0 |
| Net Income
| -64.889 | -52.484 | -45.686 | -47.558 | -36.095 | -45.935 | -56.198 | -22.308 | -19.612 | -15.979 | -7.418 | -33.488 | -18.41 | -7.147 |
| Net Income Ratio
| -62.695 | -69.7 | -26.811 | -528.422 | -11.224 | -128.31 | -497.327 | -72.429 | -69.546 | -33.998 | -4.092 | -8.723 | -2.604 | 0 |
| EPS
| -0.8 | -0.88 | -0.68 | -1.08 | -1.41 | -2.1 | -3.1 | -1.38 | -1.34 | -1.23 | -1.44 | -9.23 | -6.32 | -2.69 |
| EPS Diluted
| -0.8 | -0.88 | -0.68 | -1.08 | -1.41 | -2.1 | -3.1 | -1.38 | -1.34 | -1.23 | -1.44 | -9.23 | -6.32 | -2.69 |
| EBITDA
| -61.889 | -52.006 | -45.349 | -44.763 | -33.406 | -45.414 | -55.03 | -21.165 | -18.523 | -14.955 | -6.694 | -26.315 | -14.316 | -7.168 |
| EBITDA Ratio
| -60.944 | -69.065 | -26.613 | -526.256 | -11.123 | -127.517 | -488.186 | -68.737 | -65.684 | -31.819 | -3.692 | -6.855 | -3.587 | 0 |